<DOC>
	<DOCNO>NCT00156247</DOCNO>
	<brief_summary>To determine whether acitretin plus etanercept effective etanercept alone clear psoriasis plaque adult .</brief_summary>
	<brief_title>Acitretin Etanercept Psoriasis</brief_title>
	<detailed_description>This study include patient moderate severe psoriasis take etanercept 50 mg/week least 3 month ( 12 week ) achieve PASI 75 . They give acitretin 25 mg/day . The combined treatment occur 6 month . Subjects ' progress assess monthly , base improvement PASI PGA score .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Acitretin</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Adults ( age 18 80 year old ) moderate severe psoriasis ( defined physician global assessment score 3 [ moderate ] high ) etanercept 50 mg SQ weekly achieve PASI 75 12 week treatment etanercept All patient etanercept test TB initiation etanercept Patients &lt; 18 year old &gt; 80 year old Patients etanercept 50 mg SQ weekly Women childbearing potential ( Note : woman nonchildbearing potential , mean surgically sterile [ bilateral oophorectomy , hysterectomy , and/or bilateral tubal ligation ] postmenopausal least 2 year , eligible ) Inability understand consent comply study requirement Uncontrolled hypertriglyceridemia Patients severely impaired hepatic function Patients without health insurance willing pay outofpocket etanercept laboratory test Systemic psoriasis therapy PUVA within past 2 week UVB topical psoriasis therapy ( emollients/moisturizers OTC shampoo ) within past 1 week Patients epilepsy multiple sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>etanercept</keyword>
	<keyword>acitretin</keyword>
</DOC>